Harvard Pilgrim signs outcomes-based contracts with AstraZeneca for Brilinta and Bydureon
WELLESLEY, MA - Harvard Pilgrim Health Care has signed two innovative, outcomes-based contracts with AstraZeneca for medicines to treat acute coronary disease and Type II...




